Spain· ES:57486
RETROVIR 250 mg CAPSULAS DURAS
A medicinal product containing zidovudina, registered in Spain by Laboratorios Viiv Healthcare S.L..
Checked against AEMPS CIMA (Spain) on
Informational only — not a medical device.
The record
At a glance
AEMPS CIMA (Spain)- Active substance
- zidovudina
- Manufacturer
- Laboratorios Viiv Healthcare S.L.
- Country
- Spain (ES)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- AEMPS CIMA (Spain)
- Last checked
- September 12, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Zidovudina in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomRetrovir 250mg capsulesViiV Healthcare UK Ltd
- SwitzerlandRetrovir AZT 250 mg, KapselnViiV Healthcare GmbH
- CzechiaRETROVIRViiV Healthcare BV, Amersfoort
- FinlandRetrovirViiV Healthcare BV
- FranceRETROVIR 250 mg, géluleVIIV HEALTHCARE (PAYS-BAS)
- PolandRetrovirViiV Healthcare BV
- BelgiumRetrovir 250 mgViiV Healthcare
- SwedenRetrovir 250 mg Kapsel, hårdViiV Healthcare BV
Authorised across Europe · EMA
The same active substance is authorised in 19 EEA countries. Names it is sold under:
- Austria · Retrovir
- Belgium · Retrovir, Retrovir I.V.
- Bulgaria · Ретровир
- Czechia · Retrovir
- Germany · Retrovir, Retrovir I.V.
- Denmark · Retrovir
- Estonia · Retrovir
- Finland · Retrovir
- France · Retrovir
- United Kingdom (Northern Ireland) · Retrovir, Retrovir Iv
- Greece · Retrovir
- Ireland · Retrovir
- Italy · Retrovir
- Luxembourg · Retrovir, Retrovir I.V.
- Netherlands · Retrovir, Retrovir Infuus
- Poland · Retrovir
- Portugal · Retrovir, Retrovir Iv
- Romania · Retrovir
- Sweden · Retrovir
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of AEMPS CIMA (Spain). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/7858156f-8522-4c81-bf12-55e72b88c8e4 GET /v1/drugs/7858156f-8522-4c81-bf12-55e72b88c8e4?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cpresc": "Diagnóstico Hospitalario",
"estado": "{\"aut\":583711200000}",
"nregistro": "57486",
"substance": "zidovudina"
}See everything about zidovudina.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.